These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 5621305)
21. Hypertension in general practice. Maclean D Practitioner; 1987 May; 231(1429):649-50, 652, 655. PubMed ID: 3422897 [No Abstract] [Full Text] [Related]
22. [How can we situate new derivatives in the treatment of arterial hypertension. A short term trial]. Tcherdakoff P; Milliez P Therapeutique; 1970 Nov; 46(9):933-5. PubMed ID: 5486144 [No Abstract] [Full Text] [Related]
23. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances. Kirch W; von Gizycki C Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636 [No Abstract] [Full Text] [Related]
24. [Antihypertensive drug therapy in relation to lipid disorders]. Kawecka-Jaszcz K; Stochmal A Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649 [TBL] [Abstract][Full Text] [Related]
25. [Ciclazenine in the therapy of arterial hypertension]. Busilacchi M; Perpignano G; Altieri P; Verzetti G Rass Int Clin Ter; 1969 May; 49(10):605-14. PubMed ID: 5784807 [No Abstract] [Full Text] [Related]
26. Treatment of hypertension. Doyle AE N Y State J Med; 1968 Jan; 68(2):256-9. PubMed ID: 5235987 [No Abstract] [Full Text] [Related]
27. Considerations in the long-term treatment of hypertension. Graham RM Clin Ther; 1983; 5(3):224-33. PubMed ID: 6342783 [TBL] [Abstract][Full Text] [Related]
28. [Changes in bronchial patency in arterial hypertension patients following a regimen of hypotensive therapy]. Almazov VA; Fedoseev GB; Degtiareva ZIa; Katiukhin VN Ter Arkh; 1983; 55(3):107-9. PubMed ID: 6134348 [No Abstract] [Full Text] [Related]
29. [Should arterial hypertension in patients on regular dialysis therapy be treated with hypotensive agents?]. Sulková S; Schönová S Cas Lek Cesk; 1988 Apr; 127(15):453-5. PubMed ID: 3378248 [No Abstract] [Full Text] [Related]
30. [Sanegyt therapy of moderately severe and severe arterial hypertension]. Stankusheva G; Elenkova A Vutr Boles; 1981; 20(2):81-7. PubMed ID: 7257337 [No Abstract] [Full Text] [Related]
33. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide]. Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892 [No Abstract] [Full Text] [Related]
34. [Arterial hypertension in the elderly]. Vorburger C Ther Umsch; 1982 Feb; 39(2):117-22. PubMed ID: 7071784 [No Abstract] [Full Text] [Related]
35. [Better prognosis in hypertension and left ventricular hypertrophy. LIFE Study sets new standard]. MMW Fortschr Med; 2002 May; 144(20):60-1. PubMed ID: 12119887 [No Abstract] [Full Text] [Related]
36. [Prognosis and therapeutic possibilities in essential hypertension]. Kuhns K Clin Ter; 1967 Jul; 42(2):99-106. PubMed ID: 5596416 [No Abstract] [Full Text] [Related]
37. Reducing drug usage and adverse effects. Part II: hypertension. Baron M Health Care Food Nutr Focus; 2005 May; 22(5):7-11. PubMed ID: 15913221 [No Abstract] [Full Text] [Related]
38. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension]. Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806 [No Abstract] [Full Text] [Related]
39. [Interrelation between the hemodynamic shifts and body oxygenation levels during hypotensive therapy of middle-aged and elderly patients with arterial hypertension]. Ena LM Ter Arkh; 1980; 52(8):26-31. PubMed ID: 7256587 [No Abstract] [Full Text] [Related]
40. [Cyclazenin in the treatment of hypertension]. Gotzen R; Dissmann T Munch Med Wochenschr; 1967 Mar; 109(9):478-83. PubMed ID: 5631637 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]